References
Kager L, Cheok M, Yang W, Zaza G, Cheng Q, Panetta JC et al. Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics. J Clin Invest 2005; 115: 110–116.
Laverdiere C, Chiasson S, Costea I, Moghrabi A, Krajinovic M . Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate levels and outcome of childhood acute lymphoblastic leukemia. Blood 2002; 100: 3832–3834.
Krajinovic M, Lemieux-Blanchard E, Chiasson S, Primeau M, Costea I, Moghrabi A . Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics J 2004; 4: 66–72.
Rocha JC, Cheng C, Liu W, Kishi S, Das S, Cook EH et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 2005; 105: 4752–4758.
Schwahn B, Rozen R . Polymorphisms in the methylenetetrahydrofolate reductase gene. Clinical consequences. Am J Pharmacogenomics 2001; 1: 189–201.
Chango A, Emery-Fillon N, Potier de Courcy G, Lambert D, Pfister M, Rosenblatt DS et al. A polymorphism (80G → A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 2000; 70: 310–315.
Whetstine JW, Gifford AJ, Witt T, Liu XY, Flatley RM, Norris M et al. Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high frequency G/A variant at position 80 and transport properties of the His27 and Arg27 carriers. Clin Cancer Res 2001; 7: 3416–3422.
Gast A, Bermejo JL, Flohr T, Stanulla M, Burwinkel B, Schrappe M et al. Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case–control study. Leukemia 2007; 21: 320–325.
Dervieux T, Furst D, Lein DO, Capps R, Smith K, Walsh M et al. Polyglutamylation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum 2004; 50: 2766–2774.
Acknowledgements
Children's Cancer Institute Australia for Medical Research is affiliated with the University of New South Wales and Sydney Children's Hospital. This work was supported by grants from the National Health and Medical Research Council (Australia) (MDN, MH) and the New South Wales Cancer Council (Australia) (MDN, MH).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Rights and permissions
About this article
Cite this article
Ashton, L., Gifford, A., Kwan, E. et al. Reduced folate carrier and methylenetetrahydrofolate reductase gene polymorphisms: associations with clinical outcome in childhood acute lymphoblastic leukemia. Leukemia 23, 1348–1351 (2009). https://doi.org/10.1038/leu.2009.67
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2009.67
- Springer Nature Limited
This article is cited by
-
Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL
Scientific Reports (2016)
-
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue
Cancer Chemotherapy and Pharmacology (2012)